Terms: = Lymphoma AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4
29 results:
1. erbb4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.
Arribas AJ; Napoli S; Cascione L; Barnabei L; Sartori G; Cannas E; Gaudio E; Tarantelli C; Mensah AA; Spriano F; Zucchetto A; Rossi FM; Rinaldi A; Castro de Moura M; Jovic S; Bordone Pittau R; Stathis A; Stussi G; Gattei V; Brown JR; Esteller M; Zucca E; Rossi D; Bertoni F
Mol Cancer Ther; 2024 Mar; 23(3):368-380. PubMed ID: 38052765
[TBL] [Abstract] [Full Text] [Related]
2. Angioimmunoblastic T-cell lymphoma: Novel recurrent mutations and prognostic biomarkers by cell-free DNA profiling.
Zhang C; Mou B; Xu J; Wang J; Liu Q; Yang Y; Tang W; Zhong X; Xu C
Br J Haematol; 2023 Dec; 203(5):807-819. PubMed ID: 37646306
[TBL] [Abstract] [Full Text] [Related]
3. [Fertility preservation in female cancer patients.].
Vesztergom D; Székely B; Hegyi B; Masszi A; Pintér T; Csákó B; Kenessey I; Rubovszky G; Novák Z
Orv Hetil; 2023 Jul; 164(29):1134-1145. PubMed ID: 37481767
[TBL] [Abstract] [Full Text] [Related]
4. Life after Cleavage: The Story of a β-Retroviral (MMTV) Signal Peptide-From Murine lymphoma to Human Breast Cancer.
Hochman J; Braitbard O
Viruses; 2022 Nov; 14(11):. PubMed ID: 36366533
[TBL] [Abstract] [Full Text] [Related]
5. Genetic landscape of patients with ALK-rearranged non-small-cell lung cancer (NSCLC) and response to ceritinib in ASCEND-1 study.
Tan DS; Thomas M; Kim DW; Szpakowski S; Urban P; Mehra R; Chow LQM; Sharma S; Solomon BJ; Felip E; Camidge DR; Vansteenkiste J; Petruzzelli L; Pantano S; Shaw AT
Lung Cancer; 2022 Jan; 163():7-13. PubMed ID: 34890832
[TBL] [Abstract] [Full Text] [Related]
6. Detection of Gene Fusion Transcripts in Peripheral T-Cell lymphoma Using a Multiplexed Targeted Sequencing Assay.
Drieux F; Ruminy P; Sater V; Marchand V; Fataccioli V; Lanic MD; Viennot M; Viailly PJ; Sako N; Robe C; Dupuy A; Vallois D; Veresezan L; Poullot E; Picquenot JM; Bossard C; Parrens M; Lemonnier F; Jardin F; de Leval L; Gaulard P
J Mol Diagn; 2021 Aug; 23(8):929-940. PubMed ID: 34147695
[TBL] [Abstract] [Full Text] [Related]
7. Validity of claims-based algorithms for selected cancers in Japan: Results from the VALIDATE-J study.
de Luise C; Sugiyama N; Morishima T; Higuchi T; Katayama K; Nakamura S; Chen H; Nonnenmacher E; Hase R; Jinno S; Kinjo M; Suzuki D; Tanaka Y; Setoguchi S
Pharmacoepidemiol Drug Saf; 2021 Sep; 30(9):1153-1161. PubMed ID: 33960542
[TBL] [Abstract] [Full Text] [Related]
8. Megakaryocytes, erythropoietic and granulopoietic cells express CAL2 antibody in myeloproliferative neoplasms carrying CALR gene mutations.
Ali H; Puccio I; Akarca AU; Bob R; Pomplun S; Keong Wong W; Gupta R; Sekhar M; Lambert J; Al-Masri H; Stein H; Marafioti T
Int J Exp Pathol; 2021 Feb; 102(1):45-50. PubMed ID: 32929772
[TBL] [Abstract] [Full Text] [Related]
9. The economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapy.
Tkacz J; Garcia J; Gitlin M; McMorrow D; Snyder S; Bonafede M; Chung KC; Maziarz RT
Leuk Lymphoma; 2020 Jul; 61(7):1601-1609. PubMed ID: 32270727
[TBL] [Abstract] [Full Text] [Related]
10. Genomic characterisation of breast fibroepithelial lesions in an international cohort.
Md Nasir ND; Ng CCY; Rajasegaran V; Wong SF; Liu W; Ng GXP; Lee JY; Guan P; Lim JQ; Thike AA; Koh VCY; Loke BN; Chang KTE; Gudi MA; Lian DWQ; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Tan P; Teh BT; Tan PH
J Pathol; 2019 Dec; 249(4):447-460. PubMed ID: 31411343
[TBL] [Abstract] [Full Text] [Related]
11. Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer.
Redaelli S; Ceccon M; Zappa M; Sharma GG; Mastini C; Mauri M; Nigoghossian M; Massimino L; Cordani N; Farina F; Piazza R; Gambacorti-Passerini C; Mologni L
Cancer Res; 2018 Dec; 78(24):6866-6880. PubMed ID: 30322862
[TBL] [Abstract] [Full Text] [Related]
12. Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.
Chen R; Jin G; Li W; McIntyre TM
J Immunol; 2018 Oct; 201(7):2154-2164. PubMed ID: 30150285
[TBL] [Abstract] [Full Text] [Related]
13. Challenges in next generation sequencing analysis of somatic mutations in transplant patients.
Chen H; Luthra R; Patel KP; Routbort M; Rashid A; Roy-Chowdhuri S; Lazar A; Broaddus R; Manekia J; Singh RR; Yemelyanova A
Cancer Genet; 2018 Oct; 226-227():17-22. PubMed ID: 30005850
[TBL] [Abstract] [Full Text] [Related]
14. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
[TBL] [Abstract] [Full Text] [Related]
15. The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell-Depleted Hematopoietic Stem Cell Transplantation.
Aristei C; Carotti A; Palazzari E; Amico L; Ruggeri L; Perrucci E; Falcinelli L; Lancellotta V; Palumbo I; Falzetti F; Aversa F; Merluzzi M; Velardi A; Martelli MF
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):832-839. PubMed ID: 27623308
[TBL] [Abstract] [Full Text] [Related]
16. Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.
Boddicker RL; Razidlo GL; Dasari S; Zeng Y; Hu G; Knudson RA; Greipp PT; Davila JI; Johnson SH; Porcher JC; Smadbeck JB; Eckloff BW; Billadeau DD; Kurtin PJ; McNiven MA; Link BK; Ansell SM; Cerhan JR; Asmann YW; Vasmatzis G; Feldman AL
Blood; 2016 Sep; 128(9):1234-45. PubMed ID: 27297792
[TBL] [Abstract] [Full Text] [Related]
17. Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases.
Malapelle U; Pisapia P; Sgariglia R; Vigliar E; Biglietto M; Carlomagno C; Giuffrè G; Bellevicine C; Troncone G
J Clin Pathol; 2016 Sep; 69(9):767-71. PubMed ID: 26797410
[TBL] [Abstract] [Full Text] [Related]
18. Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of erbb4 transcripts.
Scarfò I; Pellegrino E; Mereu E; Kwee I; Agnelli L; Bergaggio E; Garaffo G; Vitale N; Caputo M; Machiorlatti R; Circosta P; Abate F; Barreca A; Novero D; Mathew S; Rinaldi A; Tiacci E; Serra S; Deaglio S; Neri A; Falini B; Rabadan R; Bertoni F; Inghirami G; Piva R;
Blood; 2016 Jan; 127(2):221-32. PubMed ID: 26463425
[TBL] [Abstract] [Full Text] [Related]
19. Outcome after HSCT in Philadelphia chromosome positive acute lymphoblastic leukemia in Sweden: a population-based study.
Hulegårdh E; Hägglund H; Ahlberg L; Karlsson K; Karbach H; Markuszewska A; Persson I; Åström M; Hallböök H
Med Oncol; 2014 Aug; 31(8):66. PubMed ID: 24965535
[TBL] [Abstract] [Full Text] [Related]
20. Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma.
Kim JW; Lee HJ; Yi HG; Kim BS; Bang SM; Kim JS; Kim I; Yoon SS; Lee JS; Kim CS; Park S; Kim BK
Am J Hematol; 2012 May; 87(5):479-83. PubMed ID: 22388671
[TBL] [Abstract] [Full Text] [Related]
[Next]
